{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T11:56:18Z","timestamp":1790682978317,"version":"4.1.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2020,6,13]],"date-time":"2020-06-13T00:00:00Z","timestamp":1592006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,6,13]],"date-time":"2020-06-13T00:00:00Z","timestamp":1592006400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100007601","name":"Horizon 2020","doi-asserted-by":"publisher","award":["666992"],"award-info":[{"award-number":["666992"]}],"id":[{"id":"10.13039\/501100007601","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014013","name":"UK Research and Innovation","doi-asserted-by":"crossref","award":["MRC MR\/S03546X\/1"],"award-info":[{"award-number":["MRC MR\/S03546X\/1"]}],"id":[{"id":"10.13039\/100014013","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100012317","name":"UCLH Biomedical Research Centre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012317","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P01 AI106705"],"award-info":[{"award-number":["P01 AI106705"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01NS083687"],"award-info":[{"award-number":["R01NS083687"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P01A107774"],"award-info":[{"award-number":["P01A107774"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Charles S. Britton Fund"},{"DOI":"10.13039\/100000030","name":"Centers for Disease Control and Prevention","doi-asserted-by":"publisher","award":["NU2GCK000434"],"award-info":[{"award-number":["NU2GCK000434"]}],"id":[{"id":"10.13039\/100000030","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010661","name":"Horizon 2020","doi-asserted-by":"crossref","award":["666992"],"award-info":[{"award-number":["666992"]}],"id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Neuropathol"],"published-print":{"date-parts":[[2020,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Sporadic Creutzfeldt\u2013Jakob disease (sCJD) is a transmissible brain proteinopathy. Five main clinicopathological subtypes (sCJD-MM(V)1, -MM(V)2C, -MV2K, -VV1, and -VV2) are currently distinguished. Histopathological evidence suggests that the localisation of prion aggregates and spongiform lesions varies among subtypes. Establishing whether there is an initial site with detectable imaging abnormalities (epicentre) and an order of lesion propagation would be informative for disease early diagnosis, patient staging, management and recruitment in clinical trials. Diffusion magnetic resonance imaging (MRI) is the most-used and most-sensitive test to detect spongiform degeneration. This study was designed to identify, in vivo and for the first time, subtype-dependent epicentre and lesion propagation in the brain using diffusion-weighted images (DWI), in the largest known cross-sectional dataset of autopsy-proven subjects with sCJD. We estimate lesion propagation by cross-sectional DWI using event-based modelling, a well-established data-driven technique. DWI abnormalities of 594 autopsy-diagnosed subjects (448 patients with sCJD) were scored in 12 brain regions by 1 neuroradiologist blind to the diagnosis. We used the event-based model to reconstruct sequential orderings of lesion propagation in each of five pure subtypes. Follow-up data from 151 patients validated the estimated sequences. Results showed that epicentre and ordering of lesion propagation are subtype specific. The two most common subtypes (-MM1 and -VV2) showed opposite ordering of DWI abnormality appearance: from the neocortex to subcortical regions, and vice versa, respectively. The precuneus was the most likely epicentre also in -MM2 and -VV1 although at variance with -MM1, abnormal signal was also detected early in cingulate and insular cortices. The caudal-rostral sequence of lesion propagation that characterises -VV2 was replicated in -MV2K. Combined, these data-driven models provide unprecedented dynamic insights into subtype-specific epicentre at onset and propagation of the pathologic process, which may also enhance early diagnosis and enable disease staging in sCJD.<\/jats:p>","DOI":"10.1007\/s00401-020-02168-0","type":"journal-article","created":{"date-parts":[[2020,6,13]],"date-time":"2020-06-13T01:02:47Z","timestamp":1592010167000},"page":"169-181","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":43,"title":["Prion propagation estimated from brain diffusion MRI is subtype dependent in sporadic Creutzfeldt\u2013Jakob disease"],"prefix":"10.1007","volume":"140","author":[{"given":"Riccardo","family":"Pascuzzo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil P.","family":"Oxtoby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra L.","family":"Young","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janis","family":"Blevins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianmarco","family":"Castelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Garbarino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark L.","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence B.","family":"Schonberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierluigi","family":"Gambetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian S.","family":"Appleby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel C.","family":"Alexander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Bizzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,6,13]]},"reference":[{"key":"2168_CR1","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2020.1319","author":"A Bizzi","year":"2020","unstructured":"Bizzi A, Pascuzzo R, Blevins J, Grisoli M, Lodi R, Moscatelli MEM et al (2020) Evaluation of a new criterion for detecting prion disease with diffusion magnetic resonance imaging. JAMA Neurol. https:\/\/doi.org\/10.1001\/jamaneurol.2020.1319","journal-title":"JAMA Neurol"},{"key":"2168_CR2","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1136\/jnnp-2017-315942","volume":"88","author":"S Baiardi","year":"2017","unstructured":"Baiardi S, Magherini A, Capellari S, Redaelli V, Ladogana A, Rossi M et al (2017) Towards an early clinical diagnosis of sporadic CJD VV2 (ataxic type). J Neurol Neurosurg Psychiatry 88:764\u2013772. https:\/\/doi.org\/10.1136\/jnnp-2017-315942","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2168_CR3","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1111\/bpa.12695","volume":"29","author":"S Baiardi","year":"2019","unstructured":"Baiardi S, Rossi M, Capellari S, Parchi P (2019) Recent advances in the histo-molecular pathology of human prion disease. Brain Pathol 29:278\u2013300. https:\/\/doi.org\/10.1111\/bpa.12695","journal-title":"Brain Pathol"},{"key":"2168_CR4","doi-asserted-by":"publisher","first-page":"2643","DOI":"10.1093\/brain\/awp196","volume":"132","author":"I Cali","year":"2009","unstructured":"Cali I, Castellani R, Alshekhlee A, Cohen Y, Blevins J, Yuan J et al (2009) Co-existence of scrapie prion protein types 1 and 2 in sporadic Creutzfeldt-Jakob disease: its effect on the phenotype and prion-type characteristics. Brain 132:2643\u20132658. https:\/\/doi.org\/10.1093\/brain\/awp196","journal-title":"Brain"},{"key":"2168_CR5","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1038\/s41598-020-58446-0","volume":"10","author":"I Cali","year":"2020","unstructured":"Cali I, Puoti G, Smucny J, Curtiss PM, Cracco L, Kitamoto T et al (2020) Co-existence of PrPD types 1 and 2 in sporadic Creutzfeldt-Jakob disease of the VV subgroup: phenotypic and prion protein characteristics. Sci Rep 10:1503. https:\/\/doi.org\/10.1038\/s41598-020-58446-0","journal-title":"Sci Rep"},{"key":"2168_CR6","doi-asserted-by":"publisher","first-page":"2278","DOI":"10.1093\/brain\/awl159","volume":"129","author":"SJ Collins","year":"2006","unstructured":"Collins SJ, Sanchez-Juan P, Masters CL, Klug GM, van Duijn C, Poleggi A et al (2006) Determinants of diagnostic investigation sensitivities across the clinical spectrum of sporadic Creutzfeldt-Jakob disease. Brain 129:2278\u20132287. https:\/\/doi.org\/10.1093\/brain\/awl159","journal-title":"Brain"},{"key":"2168_CR7","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1001\/jamaneurol.2015.3159","volume":"73","author":"L Eisenmenger","year":"2016","unstructured":"Eisenmenger L, Porter M-C, Carswell CJ, Thompson A, Mead S, Rudge P et al (2016) Evolution of diffusion-weighted magnetic resonance imaging signal abnormality in sporadic Creutzfeldt-Jakob disease, with histopathological correlation. JAMA Neurol 73:76\u201384. https:\/\/doi.org\/10.1001\/jamaneurol.2015.3159","journal-title":"JAMA Neurol"},{"key":"2168_CR8","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.1093\/brain\/awy088","volume":"141","author":"A Eshaghi","year":"2018","unstructured":"Eshaghi A, Marinescu RV, Young AL, Firth NC, Prados F, Jorge Cardoso M et al (2018) Progression of regional grey matter atrophy in multiple sclerosis. Brain 141:1665\u20131677. https:\/\/doi.org\/10.1093\/brain\/awy088","journal-title":"Brain"},{"key":"2168_CR9","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.nicl.2014.11.017","volume":"7","author":"M Figini","year":"2015","unstructured":"Figini M, Alexander DC, Redaelli V, Fasano F, Grisoli M, Baselli G et al (2015) Mathematical models for the diffusion magnetic resonance signal abnormality in patients with prion diseases. NeuroImage Clin 7:142\u2013154. https:\/\/doi.org\/10.1016\/j.nicl.2014.11.017","journal-title":"NeuroImage Clin"},{"key":"2168_CR10","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1002\/acn3.571","volume":"5","author":"NC Firth","year":"2018","unstructured":"Firth NC, Startin CM, Hithersay R, Hamburg S, Wijeratne PA, Mok KY et al (2018) Aging related cognitive changes associated with Alzheimer\u2019s disease in Down syndrome. Ann Clin Transl Neurol 5:741\u2013751. https:\/\/doi.org\/10.1002\/acn3.571","journal-title":"Ann Clin Transl Neurol"},{"key":"2168_CR11","doi-asserted-by":"publisher","first-page":"1880","DOI":"10.1016\/j.neuroimage.2012.01.062","volume":"60","author":"HM Fonteijn","year":"2012","unstructured":"Fonteijn HM, Modat M, Clarkson MJ, Barnes J, Lehmann M, Hobbs NZ et al (2012) An event-based model for disease progression and its application in familial Alzheimer\u2019s disease and Huntington\u2019s disease. Neuroimage 60:1880\u20131889. https:\/\/doi.org\/10.1016\/j.neuroimage.2012.01.062","journal-title":"Neuroimage"},{"key":"2168_CR12","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1148\/rg.2017160075","volume":"37","author":"DC Fragoso","year":"2017","unstructured":"Fragoso DC, Gon\u00e7alves Filho AL, Pacheco FT, Barros BR, Aguiar Littig I, Nunes RH et al (2017) Imaging of Creutzfeldt-Jakob disease: imaging patterns and their differential diagnosis. Radiographics 37:234\u2013257. https:\/\/doi.org\/10.1148\/rg.2017160075","journal-title":"Radiographics"},{"key":"2168_CR13","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1093\/bmb\/66.1.213","volume":"66","author":"P Gambetti","year":"2003","unstructured":"Gambetti P, Kong Q, Zou W, Parchi P, Chen SG (2003) Sporadic and familial CJD: classification and characterisation. Br Med Bull 66:213\u2013239. https:\/\/doi.org\/10.1093\/bmb\/66.1.213","journal-title":"Br Med Bull"},{"key":"2168_CR14","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1212\/WNL.0b013e3181a18846","volume":"72","author":"DN Manners","year":"2009","unstructured":"Manners DN, Parchi P, Tonon C, Capellari S, Strammiello R, Testa C et al (2009) Pathologic correlates of diffusion MRI changes in Creutzfeldt-Jakob disease. Neurology 72:1425\u20131431. https:\/\/doi.org\/10.1212\/WNL.0b013e3181a18846","journal-title":"Neurology"},{"key":"2168_CR15","doi-asserted-by":"publisher","first-page":"1994","DOI":"10.1212\/WNL.0b013e3181a96e5d","volume":"72","author":"B Meissner","year":"2009","unstructured":"Meissner B, Kallenberg K, Sanchez-Juan P, Collie D, Summers DM, Almonti S et al (2009) MRI lesion profiles in sporadic Creutzfeldt-Jakob disease. Neurology 72:1994\u20132001. https:\/\/doi.org\/10.1212\/WNL.0b013e3181a96e5d","journal-title":"Neurology"},{"key":"2168_CR16","doi-asserted-by":"publisher","first-page":"e1005416","DOI":"10.1371\/journal.ppat.1005416","volume":"12","author":"RA Moore","year":"2016","unstructured":"Moore RA, Head MW, Ironside JW, Ritchie DL, Zanusso G, Choi YP et al (2016) The distribution of prion protein allotypes differs between sporadic and iatrogenic Creutzfeldt-Jakob disease patients. PLoS Pathog 12:e1005416. https:\/\/doi.org\/10.1371\/journal.ppat.1005416","journal-title":"PLoS Pathog"},{"key":"2168_CR17","first-page":"1164","volume":"23","author":"T Murata","year":"2002","unstructured":"Murata T, Shiga Y, Higano S, Takahashi S, Mugikura S (2002) Conspicuity and evolution of lesions in Creutzfeldt-Jakob disease at diffusion-weighted imaging. Am J Neuroradiol 23:1164\u20131172","journal-title":"Am J Neuroradiol"},{"key":"2168_CR18","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1093\/brain\/awy050","volume":"141","author":"NP Oxtoby","year":"2018","unstructured":"Oxtoby NP, Young AL, Cash DM, Benzinger TLS, Fagan AM, Morris JC et al (2018) Data-driven models of dominantly-inherited Alzheimer\u2019s disease progression. Brain 141:1529\u20131544. https:\/\/doi.org\/10.1093\/brain\/awy050","journal-title":"Brain"},{"key":"2168_CR19","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1002\/ana.410390613","volume":"39","author":"P Parchi","year":"1996","unstructured":"Parchi P, Castellani R, Capellari S, Ghetti B, Young K, Chen SG et al (1996) Molecular basis of phenotypic variability in sporadic Creutzfeldt-Jakob disease. Ann Neurol 39:767\u2013778. https:\/\/doi.org\/10.1002\/ana.410390613","journal-title":"Ann Neurol"},{"key":"2168_CR20","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1007\/s00401-012-1002-8","volume":"124","author":"P Parchi","year":"2012","unstructured":"Parchi P, de Boni L, Saverioni D, Cohen ML, Ferrer I, Gambetti P et al (2012) Consensus classification of human prion disease histotypes allows reliable identification of molecular subtypes: an inter-rater study among surveillance centres in Europe and USA. Acta Neuropathol 124:517\u2013529. https:\/\/doi.org\/10.1007\/s00401-012-1002-8","journal-title":"Acta Neuropathol"},{"key":"2168_CR21","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1002\/1531-8249(199908)46:2<224::AID-ANA12>3.0.CO;2-W","volume":"46","author":"P Parchi","year":"1999","unstructured":"Parchi P, Giese A, Capellari S, Brown P, Schulz-Schaeffer W, Windl O et al (1999) Classification of sporadic Creutzfeldt-Jakob disease based on molecular and phenotypic analysis of 300 subjects. Ann Neurol 46:224\u2013233. https:\/\/doi.org\/10.1002\/1531-8249(199908)46:2<224:AID-ANA12>3.0.CO;2-W","journal-title":"Ann Neurol"},{"key":"2168_CR22","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1007\/s00401-009-0585-1","volume":"118","author":"P Parchi","year":"2009","unstructured":"Parchi P, Strammiello R, Notari S, Giese A, Langeveld JPM, Ladogana A et al (2009) Incidence and spectrum of sporadic Creutzfeldt-Jakob disease variants with mixed phenotype and co-occurrence of PrPSc types: an updated classification. Acta Neuropathol 118:659\u2013671. https:\/\/doi.org\/10.1007\/s00401-009-0585-1","journal-title":"Acta Neuropathol"},{"key":"2168_CR23","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1159\/000445768","volume":"75","author":"SY Park","year":"2016","unstructured":"Park SY, Wang MJ, Jang JW, Park YH, Lim JS, Youn YC et al (2016) The clinical stages of sporadic Creutzfeldt-Jakob disease with Met\/Met genotype in Korean patients. Eur Neurol 75:213\u2013222. https:\/\/doi.org\/10.1159\/000445768","journal-title":"Eur Neurol"},{"key":"2168_CR24","doi-asserted-by":"publisher","first-page":"13363","DOI":"10.1073\/pnas.95.23.13363","volume":"95","author":"SB Prusiner","year":"1998","unstructured":"Prusiner SB (1998) Prions. Proc Natl Acad Sci USA 95:13363\u201313383. https:\/\/doi.org\/10.1073\/pnas.95.23.13363","journal-title":"Proc Natl Acad Sci USA"},{"key":"2168_CR25","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1126\/science.1222951","volume":"336","author":"SB Prusiner","year":"2012","unstructured":"Prusiner SB (2012) Cell biology. A unifying role for prions in neurodegenerative diseases. Science 336:1511\u20131513. https:\/\/doi.org\/10.1126\/science.1222951","journal-title":"Science"},{"key":"2168_CR26","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1016\/S1474-4422(12)70063-7","volume":"11","author":"G Puoti","year":"2012","unstructured":"Puoti G, Bizzi A, Forloni G, Safar JG, Tagliavini F, Gambetti P (2012) Sporadic human prion diseases: molecular insights and diagnosis. Lancet Neurol 11:618\u2013628. https:\/\/doi.org\/10.1016\/S1474-4422(12)70063-7","journal-title":"Lancet Neurol"},{"key":"2168_CR27","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1212\/WNL.0b013e31821a4439","volume":"76","author":"P Vitali","year":"2011","unstructured":"Vitali P, Maccagnano E, Caverzasi E, Henry RG, Haman A, Torres-Chae C et al (2011) Diffusion-weighted MRI hyperintensity patterns differentiate CJD from other rapid dementias. Neurology 76:1711\u20131719. https:\/\/doi.org\/10.1212\/WNL.0b013e31821a4439","journal-title":"Neurology"},{"key":"2168_CR28","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1002\/acn3.558","volume":"5","author":"PA Wijeratne","year":"2018","unstructured":"Wijeratne PA, Young AL, Oxtoby NP, Marinescu RV, Firth NC, Johnson EB et al (2018) An image-based model of brain volume biomarker changes in Huntington's disease. Ann Clin Transl Neurol 5:570\u2013582. https:\/\/doi.org\/10.1002\/acn3.558","journal-title":"Ann Clin Transl Neurol"},{"key":"2168_CR29","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1214\/aos\/1176350366","volume":"15","author":"VJ Yohai","year":"1987","unstructured":"Yohai VJ (1987) High breakdown-point and high efficiency estimates for regression. Ann Stat 15:642\u2013665. https:\/\/doi.org\/10.1214\/aos\/1176350366","journal-title":"Ann Stat"},{"key":"2168_CR30","doi-asserted-by":"publisher","first-page":"4273","DOI":"10.1038\/s41467-018-05892-0","volume":"9","author":"AL Young","year":"2018","unstructured":"Young AL, Marinescu RV, Oxtoby NP, Bocchetta M, Yong K, Firth NC et al (2018) Uncovering the heterogeneity and temporal complexity of neurodegenerative diseases with Subtype and Stage Inference. Nat Commun 9:4273. https:\/\/doi.org\/10.1038\/s41467-018-05892-0","journal-title":"Nat Commun"},{"key":"2168_CR31","doi-asserted-by":"publisher","first-page":"2564","DOI":"10.1093\/brain\/awu176","volume":"137","author":"AL Young","year":"2014","unstructured":"Young AL, Oxtoby NP, Daga P, Cash DM, Fox NC, Ourselin S et al (2014) A data-driven model of biomarker changes in sporadic Alzheimer\u2019s disease. Brain 137:2564\u20132577. https:\/\/doi.org\/10.1093\/brain\/awu176","journal-title":"Brain"},{"key":"2168_CR32","first-page":"1551","volume":"26","author":"GS Young","year":"2005","unstructured":"Young GS, Geschwind MD, Fischbein NJ, Martindale JL, Henry RG, Liu S et al (2005) Diffusion-weighted and fluid-attenuated inversion recovery imaging in Creutzfeldt-Jakob disease: high sensitivity and specificity for diagnosis. Am J Neuroradiol 26:1551\u20131562","journal-title":"Am J Neuroradiol"},{"key":"2168_CR33","doi-asserted-by":"publisher","first-page":"2659","DOI":"10.1093\/brain\/awp191","volume":"132","author":"I Zerr","year":"2009","unstructured":"Zerr I, Kallenberg K, Summers DM, Romero C, Taratuto A, Heinemann U et al (2009) Updated clinical diagnostic criteria for sporadic Creutzfeldt-Jakob disease. Brain 132:2659\u20132668. https:\/\/doi.org\/10.1093\/brain\/awp191","journal-title":"Brain"},{"key":"2168_CR34","first-page":"155","volume-title":"Handbook of clinical neurology","author":"I Zerr","year":"2018","unstructured":"Zerr I, Parchi P (2018) Sporadic Creutzfeldt-Jakob disease. In: Pocchiari M, Manson J (eds) Handbook of clinical neurology, vol 153. Elsevier, Amsterdam, pp 155\u2013174"}],"container-title":["Acta Neuropathologica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00401-020-02168-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00401-020-02168-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00401-020-02168-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,12]],"date-time":"2021-06-12T19:23:27Z","timestamp":1623525807000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00401-020-02168-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,13]]},"references-count":34,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["2168"],"URL":"https:\/\/doi.org\/10.1007\/s00401-020-02168-0","relation":{},"ISSN":["0001-6322","1432-0533"],"issn-type":[{"value":"0001-6322","type":"print"},{"value":"1432-0533","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,13]]},"assertion":[{"value":"19 March 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 May 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 June 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors report no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Written informed consent was provided by the patient or legal next of kin for autopsy through the CDC-funded NPDPSC Autopsy Program (\n                      \n                      ). This study was approved by the University Hospitals Institutional Review Board and informed consent was waived on deceased subjects for the purpose of this study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Research involving humans"}}]}}